Epsilon-aminocaproic acid

ε-アミノカプロン酸

Cross-market regulatory comparison. Markets are ordered by constraint severity.

Most Constrained Market

EU — Prohibited

EU Prohibited

1 rule

prohibited EU CosIng Annex Substances

as a constituent of other substances, or in mixtures, in concentrations equal to, or greater than 0.1% by weight; Shall not be placed on the market, or used, as substance or in mixtures in concentrations equal to ot greater than 0.1% by weight

EU CosIng Annex II / Ref 7

This comparison is based on rule data from official regulatory sources. Markets with no rules are not shown. Regulatory status can change; verify with official sources before making compliance decisions. This tool is for informational purposes only.

Legal Disclaimer

This service is provided "AS IS" without warranties of any kind. Regulatory data is for reference only and does not constitute legal or regulatory advice. Always consult a qualified attorney or regulatory consultant before making compliance decisions. Not affiliated with the U.S. Food and Drug Administration (FDA) or any government agency. IngredientCompliance is an independent tool operated by Gerim-Sterling LLC. © 2026 Gerim-Sterling LLC.

Dispute Resolution — Binding Arbitration: By using this service, you agree that any dispute, claim, or controversy arising out of or relating to these terms or the use of this service shall be resolved exclusively through final and binding individual arbitration administered by the American Arbitration Association (AAA) under its Consumer Arbitration Rules, and not in any court. You waive any right to participate in a class action lawsuit or class-wide arbitration. Arbitration shall be conducted remotely via video conference under AAA's Consumer Arbitration Rules, with no required physical appearance. This clause does not prevent either party from seeking emergency injunctive relief in a court of competent jurisdiction where necessary to prevent irreparable harm.